Trial of Ixazomib for Kaposi Sarcoma

NCT04305691 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

41

Enrollment

NETWORK

Sponsor class

Conditions

Kaposi Sarcoma
Skin

Interventions

DRUG: Ixazomib Citrate
OTHER: Quality-of-Life Assessment
OTHER: Questionnaire Administration

Sponsor

AIDS Malignancy Consortium

Collaborators

[object Object]